SCHEMBL24316522

SCHEMBL24316522

Cc1cnc2ccc(F)cn2c1=O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
PIK3CA P42336 1/20 0.46
MTOR P42345 1/20 0.46
KDM4E B2RXH2 2/20 0.43
CYP11B1 P15538 5/20 0.41
CYP11B2 P19099 5/20 0.41
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
ADORA2A P29274 1/20 0.39
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
JAK2 O60674 4/20 0.37
JAK3 P52333 4/20 0.37
JAK1 P23458 3/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
FADS1 O60427 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688112 0.82 KDM4E (0.56) ALDH1A1HPGDKDM4ECYP11B1CYP11B2
SCHEMBL17383465 0.79 RXFP1 (0.43) ALDH1A1HPGDPIK3CAMTORKDM4E
SCHEMBL24316647 0.79 KDM4E (0.43) ALDH1A1HPGDPIK3CAMTORKDM4E
SCHEMBL24316788 0.79 KDM4E (0.43) ALDH1A1HPGDPIK3CAMTORKDM4E
SCHEMBL14041215 0.78 TGFBR1 (0.43) ALDH1A1HPGDCYP11B1CYP11B2ADORA2A
SCHEMBL24316477 0.76 KDM4E (0.41) ALDH1A1HPGDPIK3CAMTORKDM4E
SCHEMBL24316735 0.74 CYP11B2 (0.41) ALDH1A1HPGDKDM4ECYP11B1CYP11B2
SCHEMBL28417731 0.74 FLT3 (0.49) PIK3CAMTORADORA2APRMT5WDR77
SCHEMBL10518268 0.71 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL23889036 0.71 ADORA2A (0.53) PIK3CAADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240092774-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2024-03-21 US disclosed
EP-4214198-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF Hutchison Medipharma Limited (CN) 2023-07-26 EP disclosed
WO-2022057895-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2022-03-24 WO disclosed
WO-2022057895-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2022-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240092774-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF CYP2D6, CYP3A7, CYP2F1 ALDH1A1 169/4885HPGD 115/4885PIK3CA 2391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.